Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Cheaper dialysis filters may work just as well in Kids' heart surgery

NCT ID NCT06792565

Knowledge-focused Sponsor: Alnas Hospital Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study looked at 60 children having heart surgery with a bypass machine. It compared two types of filters—hemofilters and hemodialyzers—to see which one better removes inflammatory substances called cytokines. The goal was to find out if the cheaper hemodialyzer could be a safe alternative.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

What this could lead to
If successful, this could show that cheaper hemodialyzers work as well as hemofilters for reducing inflammation during pediatric heart surgery.
What could go wrong
This is a small, completed study with only 60 children, so results may not apply to all patients or settings. It compares devices, not a new treatment.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

60 people

The number who actually took part.

Started

Mar 2024

Finished

Oct 2025

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

Up to 15 years

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: 1. Pediatric patients who are undergoing elective cardiothoracic surgery which cardiopulmonary bypass will be conducted. 2. Age of patients from 1 year to 15 years. 3. CPB duration more than 60 minutes. Exclusion Criteria: 1. Pediatric patients with known signs of sepsis. 2. Pediatric patients having had previous cardiothoracic surgery. 3. Preoperative renal failure. 4. Preoperative cardiogenic shock requiring the use of inotropes. 5. Preoperative lactate concentration \> 2 mmol/L.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Cardio-pulmonary bypass are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

congenital heart disease

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Cardio-pulmonary bypass Cytokine

Contacts and locations

Locations

  • Alnas Hospital

    Shubrā al Khaymah, Egypt

More trials for these conditions

Other studies related to the condition(s) this trial covers.